Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion type Assertion NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_head.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion wasGeneratedBy ECO_0000203 NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion wasDerivedFrom befree-2016 NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion SIO_000772 22710719 NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion evidence source_evidence_literature NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion description "[The CML is nowadays successfully treated with BCR-ABL kinase inhibitors as imatinib and dasatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.